Clinical Trial Update: The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of atorvastatin on the nitric oxide system in patients with Type 2 diabetes and nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Erling Bjerregaard Pedersen | Conditions: Nephropathy, Cardiovascular Diseases | Phase 2 | Status: COMPLETED